SCHEDULE: Wellington Management Boosts Immunocore Stake

Wellington Management Group LLP and its affiliates have reported a 10.2% beneficial ownership stake in Immunocore Holdings plc common stock as of July 31, 2025.

Summary

• Wellington Management Group LLP, along with its affiliates Wellington Group Holdings LLP, Wellington Investment Advisors Holdings LLP, and Wellington Management Company LLP, collectively hold a beneficial ownership of 5,132,898 shares of Immunocore Holdings plc Common Stock.
• This aggregate beneficial ownership represents 10.2% of the class of securities.
• The reporting persons have shared voting power over 4,958,998 shares and shared dispositive power over 5,132,898 shares.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing the control of Immunocore Holdings plc.

Sentiment

Score: 6

Explanation: The filing is a routine beneficial ownership disclosure, indicating a significant stake by a major institutional investor, which can be viewed as a positive signal of confidence, though it does not contain performance-related information.

Positives

• A significant beneficial ownership stake of 10.2% by a major institutional investor like Wellington Management Group LLP can signal confidence in the company's long-term prospects.
• The filing confirms that the shares are held in the ordinary course of business, indicating a passive investment rather than an activist intent to influence control.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional holder provides transparency regarding the company's ownership structure and may influence investor perception.

Key Dates

Keywords

Immunocore Holdings, Wellington Management, Beneficial Ownership, SEC Filing, Schedule 13G, Common Stock, Institutional Investor